{"meshTags":["Stomach Ulcer","Peptic Ulcer Perforation","Female","Drug Combinations","Chronic Disease","Injections, Intramuscular","Adult","Tromethamine","Gastrointestinal Hemorrhage","Ketorolac Tromethamine","Tolmetin","Anti-Inflammatory Agents, Non-Steroidal","Humans","Analgesics","Pancreatitis"],"meshMinor":["Stomach Ulcer","Peptic Ulcer Perforation","Female","Drug Combinations","Chronic Disease","Injections, Intramuscular","Adult","Tromethamine","Gastrointestinal Hemorrhage","Ketorolac Tromethamine","Tolmetin","Anti-Inflammatory Agents, Non-Steroidal","Humans","Analgesics","Pancreatitis"],"publicationTypes":["Case Reports","Journal Article"],"abstract":"Peptic ulcers, perforations, and serious gastrointestinal bleeding have not been reported with intramuscular ketoralac tromethamine, the first parenteral nonsteroidal anti-inflammatory drug available for analgesic use. This article presents the case of a 39-year-old black female who underwent surgical repair of a perforated gastric ulcer after receiving multiple dosages of intramuscular ketoralac tromethamine in the emergency room over a period of 21/2 months for the treatment of pain due to chronic pancreatitis.","title":"Intramuscular Toradol, gastrointestinal bleeding, and peptic ulcer perforation: a case report.","pubmedId":"7731074"}